Skip to main content

Table 3 Clinical description, molecular and cellular results of the 40 NER-defective patients studied by NGS

From: Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing

Patient #

Gender

Clinical indication

Intellectual disability/psychomotor delay

Growth failure

Micro-cephaly

Photo-sensitivity

Neuro-sensorial impairement

Cancer

RRS

UDS

NGS diagnosis

Mutated gene

Mutations (c.)

Mutations (p.)

Parentation segregation

1

F

CS

+

+

+

+

+

-

↓

NA

+

ERCC6(CSB)

c.[(?_-164)_(−15+44+1_136-1)];[2047C>T]

p.[?];[Arg683*]

+ (only mother)

2

M

CS

+

+

+

+

+

-

↓

NA

+

ERCC6(CSB)

c.[2599-26A>G];[4115delG]

p.[Met867Thrfs*14];[Gly1372Glufs*22]

+

3

M

CS

+

+

+

NA

+

-

NA

NA

+

ERCC6(CSB)

c.[2060C>T];[3862C>T]

p.[Ser687Leu];[Arg1288*]

+

4

M

CS

+

+

NA

+

-

-

↓

N

+

ERCC6(CSB)

c.[543G>T];[543+4delA]

p.[Lys181Asn];[?]

+

5

F

CS

+

+

+

+

+

-

NA

NA

+

ERCC8(CSA)

c.[927delT];[1041+1G>T]

p.[Phe309Leufs*19];[?]

+

6

F

CS

+

+

+

++

+

-

↓

N

+

ERCC8(CSA)

c.[356C>T(;)618-1G>A]

p.[Ser119Leu(;)?]

NA

7

M

CS

+

+

+

+

-

-

↓

NA

+

ERCC8(CSA)

c.[611C>A];[1122+1delG]

p.[Thr604Lys];[?]

+ (only mother)

8

M

CS

+

-

-

+

+

-

I

N

+

ERCC8(CSA)

c.[730C>T];[730C>T]

p.[His244Tyr];[His244Tyr]

+

9

M

CS

+

+

+

+

+

-

I

NA

+

ERCC8(CSA)

c.[793A>C];[793A>C]

p.[Thr265Pro];[Thr265Pro]

+

10

F

XP

-

NA

-

+

-

+

N

N

+

POLH

c.[764+1G>A(;)1445C>A]

p.[?(;)Ser482*]

NA

11

F

XP

-

NA

NA

+

-

+

N

N

+

POLH

c.[764+1G>A(;)764+1G>A]

p.[?(;)?]

NA

12

F

XP

-

NA

-

+

-

+

N

N

+

POLH

c.[764+1G>A(;)764+1G>A]

p.[?(;)?]

NA

13

M

XP

-

NA

NA

+

NA

+

N

N

+

POLH

c.[764+1G>A];[764+1G>A]

p.[?];[?]

+

14

M

CS

+

-

+

++

+

-

NA

↓

+

ERCC2(XPD)

c.[1847G>C];[2047C>T]

p.[Arg616Pro];[Arg683Trp]

+ (only mother)

15

F

UVSS

-

-

-

++

-

-

NA

↓

+

ERCC2(XPD)

c.[2047C>T];[2047C>T]

p.[Arg683Trp];[Arg683Trp]

+

16

F

CS

+

+

+

+

-

-

↓

↓

+

ERCC5(XPG)

c.[2200-10C>G];[2200-10C>G]

p.[?];[?]

+

17

M

UVSS

-

-

-

++

+

-

↓

↓

+

ERCC3(XPB)

c.[296T>C(;)325C>T]

p.[Phe99Ser(;)Arg109*]

NA

18

M

CS

+

+

+

-

+

-

NA

NA

-

    

19

F

CS

+

+

+

NA

+

-

N

↓

-

    

20

F

XP

+

+

NA

++

+

-

NA

NA

-

    

21

M

CS

+

+

+

NA

-

-

N

N

-

    

22

F

CS

+

+

+

-

+

-

I

N

-

    

23

M

CS

+

+

+

NA

+

-

I

NA

-

    

24

F

CS

+

+

-

-

-

-

N

N

-

    

25

M

CS

+

+

+

-

-

-

N

NA

-

    

26

F

CS

+

+

+

-

-

-

N

N

-

    

27

M

CS

-

+

+

-

+

-

NA

NA

-

    

28

M

COFS

NA

+

+

NA

+

-

N

N

-

    

29

M

CS

+

+

+

+

+

-

NA

NA

-

    

30

F

CS

+

+

+

+

+

-

N

↓

-

    

31

M

CS

+

+

+

-

+

-

NA

NA

-

    

32

F

CS

+

+

+

+

-

-

↓

N

-

    

33

M

CS

+

+

+

-

-

-

N

N

-

    

34

F

CS

+

+

+

-

-

-

NA

NA

-

    

35

F

CS

+

+

+

-

+

-

NA

NA

-

    

36

F

CS

+

+

+

-

+

-

NA

NA

-

    

37

M

CS

+

+

+

-

+

-

NA

NA

-

    

38

F

CS

+

+

+

NA

+

-

NA

NA

-

    

39

F

COFS

NA

+

+

NA

NA

-

NA

NA

-

    

40

M

COFS

NA

+

+

NA

NA

-

N

I

-

    
  1. Undescribed variations are in bold. Variations are described according to the latest nomenclature conventions described in HGVS. I: inconclusive results, N: normal; NA: not available; RRS: recovery of RNA synthesis; UDS: unscheduled DNA synthesis